← Leaderboards
Frank Stappenbeck
Max Biopharma, Inc.
$4,144,465
Attributed
$4,144,465
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $975K · FY2013–19$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,144,465 · 4
By mechanism
R44$3,847,935 · 2
R43$296,530 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Osteoblasts”
- Gerard Karsenty · University Of Texas Md Anderson Can Ctr$29,617,439
- Clifford J Rosen · Icahn School Of Medicine At Mount Sinai$20,700,088
- Henry M Kronenberg · Massachusetts General Hospital$20,551,682
- Brendan Hl Lee · Baylor College Of Medicine$20,273,696
- Stavroula Kousteni · Columbia University Health Sciences$19,552,379
- Ernesto Canalis · University Of Connecticut Sch Of Med/Dnt$18,574,878
Research focus
OsteoblastsOsteogenicIn Vitro ActivityMesenchymal Stem CellsOsteoblast DifferentiationOsteogenesisForteoIn VitroMediatingLipid BiosynthesisFda ApprovedBoneBone DensityAmericanAnabolic AgentsBone LossBone ResorptionAnimalsIn VivoCholesterolBlood CirculationBisphosphonateAffectOsteoporosis
Grant awards (8)
Preclinical Development of Oxy200 for the Treatment of Osteoporosis$975,009
R44 · FY2019 · AG · contact PI
Preclinical Development of Oxy200 for the Treatment of Osteoporosis$975,009
R44 · FY2018 · AG · contact PI
Design and synthesis of bone-selective osteogenic oxysterol-bisphosphonate analogues$499,690
R44 · FY2017 · AG · contact PI
Synthesis of bone-selective osteogenic oxysterols$450,621
R44 · FY2017 · AR · contact PI
Design and synthesis of bone-selective osteogenic oxysterol-bisphosphonate analogues$498,960
R44 · FY2016 · AG · contact PI
Synthesis of bone-selective osteogenic oxysterols$448,646
R44 · FY2016 · AR · contact PI
Design and synthesis of bone-selective osteogenic oxysterol-bisphosphonate analog$149,342
R43 · FY2014 · AR · contact PI
Synthesis of bone-selective osteogenic oxysterols$147,188
R43 · FY2013 · AR · contact PI